Zhejiang Langhua Pharmaceutical Co., Ltd, is a comprehensive pharmaceutical company engaged in research and development, production, marketing and sourcing of pharmaceutical products. As the subsidiary of world leading drug discovery CRO company Viva bio-tech holdings, Langhua offers our worldwide partners One-Stop CDMO solution in new drug full life-cycle read morefor small molecule Active Pharmaceutical Ingredients (APIs) and Finished Dosage Form, from pre-clinical to commercial supply. Langhua is the leading manufacturer of Spironolactone, Olanzapine, Antivirus and fluoroquinolones in the world, offers our global customers the high-quality and competitive Generic APIs. [website]

Founded in 2003, Laviana Pharma defines itself as a technology-driven enterprise focusing on innovative drug process research and manufacture outsourcing(CDMO). Laviana Pharma covers the whole process of pharmaceutical services (CMC) from laboratory to commercialization of small-molecule innovative drugs. [website]

LinkChem, founded in 2011, is a comprehensive high-tech enterprise integrating drug R&D and production. The core business covers building blocks, intermediates, API, new material small molecular. LinkChem has partnered with over 4,000 pharmaceutical companies and R&D institutions around the world. Guided by market needs, LinkChem drives technological development read morethrough innovation on the basis of "Science, Rigor, Innovation, Cooperation" development philosophy. LinkChem is committed to establishing a professional one-stop CDMO platform for biomedicine. [website]

At Lonza Small Molecules, our connected experts work together to provide contract development and manufacturing services, helping pharma and small biotech companies deliver their medicines to patients in need. From the earliest stages of discovery to the final drug product, we can simplify your outsourcing read moreexperience with our reliable, timely service, anticipating risks and solving problems. Whether you are developing a pioneering therapy or creating a new oral solid dosage form, Lonza is the only CDMO partner you need. Throughout your molecule’s journey from early development to commercial product, we work as one